AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.150
-0.030 (-0.94%)
At close: Dec 23, 2025, 4:00 PM EST
3.150
0.00 (0.00%)
After-hours: Dec 23, 2025, 4:00 PM EST

AC Immune Revenue

AC Immune had revenue of 939.00K CHF in the quarter ending September 30, 2025, a decrease of -96.32%. This brings the company's revenue in the last twelve months to 4.37M, down -89.33% year-over-year. In the year 2024, AC Immune had annual revenue of 27.31M with 84.51% growth.

Revenue (ttm)
4.37M CHF
Revenue Growth
-89.33%
P/S Ratio
58.28
Revenue / Employee
25,419 CHF
Employees
172
Market Cap
311.67M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202427.31M12.51M84.51%
Dec 31, 202314.80M10.87M276.14%
Dec 31, 20223.94M--
Dec 31, 2021---
Dec 31, 202015.43M-95.03M-86.03%
Dec 31, 2019110.46M103.54M1,498.03%
Dec 31, 20186.91M-13.34M-65.88%
Dec 31, 201720.26M-2.96M-12.75%
Dec 31, 201623.21M-15.88M-40.61%
Dec 31, 201539.09M8.82M29.14%
Dec 31, 201430.27M21.63M250.46%
Dec 31, 20138.64M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings